Arthritis  >>  andecaliximab (GS-5745)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
andecaliximab (GS-5745) / Gilead
NCT02176876: Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

Completed
1b
18
Europe
GS-5745, Placebo to match GS-5745
Gilead Sciences
Rheumatoid Arthritis
04/15
06/15

Download Options